CN109797115B - Bacillus amyloliquefaciens GZU05 for producing nattokinase and beta-glucoside and application method thereof - Google Patents
Bacillus amyloliquefaciens GZU05 for producing nattokinase and beta-glucoside and application method thereof Download PDFInfo
- Publication number
- CN109797115B CN109797115B CN201910025309.9A CN201910025309A CN109797115B CN 109797115 B CN109797115 B CN 109797115B CN 201910025309 A CN201910025309 A CN 201910025309A CN 109797115 B CN109797115 B CN 109797115B
- Authority
- CN
- China
- Prior art keywords
- nattokinase
- gzu05
- beta
- bacillus amyloliquefaciens
- glucosidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010073682 nattokinase Proteins 0.000 title claims abstract description 46
- 229940086319 nattokinase Drugs 0.000 title claims abstract description 45
- 241000193744 Bacillus amyloliquefaciens Species 0.000 title claims abstract description 31
- 150000008495 β-glucosides Chemical class 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title abstract description 27
- 238000004321 preservation Methods 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 abstract description 44
- 102000004190 Enzymes Human genes 0.000 abstract description 43
- 108090000790 Enzymes Proteins 0.000 abstract description 43
- 230000000694 effects Effects 0.000 abstract description 37
- 102000006995 beta-Glucosidase Human genes 0.000 abstract description 36
- 108010047754 beta-Glucosidase Proteins 0.000 abstract description 36
- 235000011201 Ginkgo Nutrition 0.000 abstract description 31
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract description 31
- 244000068988 Glycine max Species 0.000 abstract description 20
- 235000010469 Glycine max Nutrition 0.000 abstract description 20
- 235000013557 nattō Nutrition 0.000 abstract description 12
- 230000001953 sensory effect Effects 0.000 abstract description 11
- 229930182486 flavonoid glycoside Natural products 0.000 abstract description 10
- 150000007955 flavonoid glycosides Chemical class 0.000 abstract description 10
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 239000001963 growth medium Substances 0.000 abstract description 9
- 238000012258 culturing Methods 0.000 abstract description 7
- 244000046052 Phaseolus vulgaris Species 0.000 abstract description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract description 5
- 239000007787 solid Substances 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 3
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 230000002906 microbiologic effect Effects 0.000 abstract 1
- 241000218628 Ginkgo Species 0.000 description 30
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 19
- 229930003944 flavone Natural products 0.000 description 19
- 235000011949 flavones Nutrition 0.000 description 19
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 19
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 13
- -1 flavone glycoside Chemical class 0.000 description 13
- 229930182470 glycoside Natural products 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 11
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229960001031 glucose Drugs 0.000 description 10
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 9
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 229960005356 urokinase Drugs 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 150000002212 flavone derivatives Chemical class 0.000 description 7
- 230000003301 hydrolyzing effect Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 230000009089 cytolysis Effects 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000005491 wire drawing Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 3
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 3
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 3
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000003794 Gram staining Methods 0.000 description 3
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 3
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010563 solid-state fermentation Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000002537 thrombolytic effect Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 229920001543 Laminarin Polymers 0.000 description 2
- 239000005717 Laminarin Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 2
- 108010023197 Streptokinase Proteins 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 229940089837 amygdalin Drugs 0.000 description 2
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 2
- 229940127217 antithrombotic drug Drugs 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 2
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229960005202 streptokinase Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Abstract
Bacillus amyloliquefaciens GZU05 capable of producing nattokinase and beta-glucoside, is classified and named as Bacillus amyloliquefaciens GZU05 according to microbiological classification, and has the following chemical name: bacillus amyloliquefaciens GZU05 which is preserved in China center for type culture collection (CCTCC M2018763) in 11-9.2018. It is collected from traditional fermented bean products of Guizhou, namely fermented soya beans. The application method comprises culturing the selected strain GZU05 with solid fermented natto culture medium to produce beta-glucosidase and nattokinase, and obtaining fermented soybean product rich in nattokinase. The GZU05 of the invention can be used for high-value conversion of ginkgo flavonoid glycoside and can produce nattokinase with high value, the enzyme activity of the nattokinase is high, the sensory property is good, and the invention is suitable for being popularized and applied to producing the nattokinase.
Description
Technical Field
The invention relates to a microorganism, an enzyme, bacillus amyloliquefaciens and an application method of the bacillus amyloliquefaciens.
Background
beta-Glucosidase (beta-D-Glucosidase, EC3.2.1.21) is a broad-source hydrolase. The characteristic is that the beta-D-glucose can be hydrolytically bonded to a terminal non-reducing beta-D-glucose glycosidic bond and release beta-glucose and corresponding ligands. The beta-glucosidase may be produced by yeast, aspergillus, trichoderma, bacteria, etc. According to the reports at home and abroad, the enzyme can be widely used for the biotransformation of flavonoids.
The production of enzymes by microbial fermentation is an effective way for biological enzyme sources. Domestic and foreign research shows that the microbial fermentation enzyme production can hydrolyze ginkgo flavone glycoside into ginkgo flavone aglycone, so that the aglycone activity is obviously higher than that of the ginkgo flavone glycoside. The ginkgo flavone is the best medicament for preventing and treating cardiovascular and cerebrovascular diseases, and currently, the ginkgo flavone is mainly extracted from ginkgo leaves, but the ginkgo flavone extracted from the ginkgo leaves mainly exists in the form of ginkgo flavone glycoside, while the biological activity of the ginkgo flavone glycoside is obviously less than that of the ginkgo flavone aglycone, and the enzymatic method is environment-friendly and has high selectivity, so that the ginkgo flavone glycoside is necessarily converted into the aglycone by utilizing beta-glucosidase.
At present, although the research results on beta-glucosidase are more, most microorganisms are from the nature and are from the traditional fermented food, and the research results are only reported. In addition, the traditional enzymes have poor substrate selectivity and cannot maximize the content of aglycone, and reports of hydrolyzing the ginkgo flavone glycoside into aglycone with high selectivity are few. Wuyi et al use fixed commercial beta-glucosidase to hydrolyze ginkgo flavone glycoside, and obtain better results. However, the hydrolysis of ginkgo flavonoid glycosides by non-commercial beta-glucosidase is rarely reported, and because commercial beta-glucosidase is expensive, the screening of beta-glucosidase strains producing hydrolyzed ginkgo flavonoid glycosides lays a foundation for the industrial production of ginkgo flavonoid aglycones, and the reduction of conversion cost is very important.
The human health is seriously affected by thrombotic diseases, according to statistics, at least 1200 million patients die of thrombotic diseases every year around the world, and about 260 million patients die of China. Therefore, the development of thrombolytic and antithrombotic drugs has been a hot point related to human health. Currently, Streptokinase (SK), Urokinase (UK) and tissue plasminogen activator (t-PA) are commonly used thrombolytic antithrombotic drugs in clinic, but these drugs have the disadvantages of pain in administration, large side effect, high price, short half-life and the like. And the nattokinase has the advantages of oral taking, safety, low price, strong fiber solubility and the like, and becomes a research hotspot of thrombolytic products in recent years.
In a Chinese patent database, a plurality of patents and application parts related to beta-glucosidase exist, for example, ZL2014106023384, namely a beta-glucosidase and beta-glucosidase mutant and application, ZL2015101756557, high-tolerance beta-glucosidase and application, 2017102790450, namely a strain of beta-glucosidase producing bacteria for hydrolyzing ginkgetin glycoside and a screening method thereof, and the like; however, no application related to Bacillus amyloliquefaciens GZU05 is available.
Disclosure of Invention
The invention aims to provide a bacillus amyloliquefaciens GZU05 capable of producing nattokinase and beta-glucoside enzymolysis, which has important effects on the beta-glucosidase capable of selectively hydrolyzing ginkgo flavonoid glycoside produced by fermented soya beans and the nattokinase for preventing and treating cardiovascular and cerebrovascular diseases.
The invention also aims to provide a method for applying the bacillus amyloliquefaciens to producing flavone aglycone and producing natto kinase rich fermented soybean.
The bacillus amyloliquefaciens GZU05 capable of producing nattokinase and beta-glucoside enzymolysis provided by the inventor is classified and named as bacillus amyloliquefaciens GZU05 and Latin literature name: bacillus amyloliquefaciens GZU05 which is preserved in the China center for type culture Collection in 11.9.2018 has the preservation number of CCTCC M2018763, the preservation unit address is Wuhan, Wuhan university, the postal code is 430072, and the telephone number is 027-.
The bacillus amyloliquefaciens GZU05 is collected from traditional fermented soybean product fermented soya beans in Guizhou, and has the performance of producing beta-glucosidase for selectively hydrolyzing ginkgo flavonoid glycoside and producing nattokinase.
The method for applying the bacillus amyloliquefaciens to producing flavonoid aglycone and producing fermented soybeans rich in nattokinase provided by the inventor comprises the following steps:
(1) Properly diluting a fermented bean product sample, coating the diluted fermented bean product sample on a gardenoside color development plate, culturing the diluted fermented bean product sample by using a gardenoside color development screening culture medium prepared in advance, screening out a strain with a large blue colony and a dark color, carrying out scribing, separation and purification on the strain, and carrying out slant preservation and glycerol preservation for later use after the strain is detected as a single strain by a gram staining microscope;
(2) converting ginkgo flavone by using strain fermentation liquor, and determining the enzyme activity of beta-glucosidase; simultaneously measuring the enzyme activity of the nattokinase, carrying out sensory evaluation on the natto product, and selecting a natto fermentation strain GZU05 which has high activity of beta-glucosidase and nattokinase and optimal comprehensive sensory evaluation;
(3) performing morphological analysis, physiological and biochemical determination and 16S rRNA sequence analysis on the strain GZU05 to determine that the strain belongs to the bacillus amyloliquefaciens;
(4) culturing the bacillus amyloliquefaciens GZU05 by using a solid fermented natto culture medium, producing nattokinase and beta-glucosidase by fermented natto, and fermenting for 48-72 hours; obtaining the fermented soybean product rich in nattokinase.
In the step (1) of the method, the formula of the gardenoside chromogenic screening culture medium is as follows: 5 parts of ginkgo leaf extract, 0.5 part of magnesium sulfate, 10 parts of monopotassium phosphate, 0.1 part of geniposide, 10 parts of sodium glutamate, 2 parts of ammonium sulfate and 20 parts of agar; the culture temperature is 37 ℃, and the culture time is 36-72 h.
In the step (2) of the method, the unit of enzyme activity is the amount of enzyme required by hydrolyzing the ginkgo flavone glycoside to generate 1 mu mol of reducing sugar on a glucose basis every 1min under the measuring condition, and is defined as an enzyme activity unit.
In the step (2) of the above method, the method for measuring β -glucosidase comprises: taking a 15mL test tube with a plug scale, adding 1.8mL of substrate, preheating at 50 ℃ for 3min, adding 0.2mL of glucosidase enzyme solution, bathing at 50 ℃ for 30min, adding 3mL of DNS reagent, bathing in boiling water for 10min, cooling and fixing the volume to 15 mL. Taking the inactivated enzyme solution as a blank control, measuring a light absorption value at 540nm, and measuring the content of the generated reducing sugar; the method for measuring the enzyme activity of the nattokinase comprises the following steps: taking 10 mu L of nattokinase solid state fermentation crude enzyme liquid to be spotted on a fibrin flat plate (four holes are parallel in one group), standing for 10min, moving into an incubator at 37 ℃, keeping the temperature for 16h, taking out, measuring the diameter of a lysis ring by using a vernier caliper, calculating the area of each lysis ring, and calculating the enzyme activity of the nattokinase according to a regression equation of a urokinase standard curve; the sensory evaluation method of the fermented soybean product rich in nattokinase comprises the following steps: after fermentation, the fermented product is scored by a weighting method, and sensory evaluation is carried out on 4 aspects of wire drawing (viscosity), color, smell and posture.
In the above step, the substrate is 1% of one of ginkgo flavone glycoside or amygdalin, geniposide, rutin, gentiobiose, maltotriose, arbutin, laminarin and trehalose.
In the step (4) of the above method, the medium is prepared by the following method: cleaning soybeans, removing mildewed, rotten, worm-eaten and malformed soybeans, removing impurities, washing the soybeans with deionized water, accurately weighing, adding 4 times of deionized water in which 1% of salt and 1% of glucose are dissolved by volume, completely immersing the soybeans at normal temperature for 18-24 hours, and thus obtaining the soybean milk.
In the step (4), the beta-glucosidase has high selectivity on the ginkgo flavonoid glycoside, the enzyme activity of hydrolyzing the ginkgo flavonoid glycoside is 4.2U/g, the enzyme can be stored for 2-4 days at room temperature and for 7-10 days at 4 ℃, the conversion capacity of the enzyme is kept above 45%, and the enzyme activity of the nattokinase produced by fermenting natto exceeds 6000U/g.
Compared with the prior art, the invention has the following advantages: the conversion rate of the biological compound enzyme prepared by the invention to the substrate ginkgetin can reach 88 percent, and the conversion rate of beta-glucosidase to the substrate ginkgetin can reach 45 percent; the fermentation method has simple process and raw materials, and reduces the production cost of the beta-glucosidase; and the environmental tolerance of the enzyme is obviously improved compared with the beta-glucosidase reported in the literature: the tolerance pH2.8-5.5, and the tolerance temperature 40-70 ℃; the conversion reaction can be continuously carried out, and the method is suitable for large-scale continuous production; ② the beta-glucosidase enzyme activity of the bacillus amyloliquefaciens GZU05 is 4.022U/g, the enzyme activity of the nattokinase is 5786.1 +/-510.9, and the bacillus amyloliquefaciens has the function of converting the ginkgo flavonoid glycoside into aglycone. The produced natto kinase has high enzyme activity and good sensory property, and is easy to be accepted by the public; the bacillus amyloliquefaciens GZU05 can be used for high-value transformation of ginkgo flavonoid glycoside and production of high-value nattokinase, and simultaneously provides a novel culture method for producing beta-glucosidase and nattokinase, and has high safety; because the soybeans are wide in source and moderate in price, the production cost of beta-glucosidase and nattokinase is reduced. Therefore, the bacillus amyloliquefaciens has good application prospect.
Drawings
FIG. 1 is a glucose concentration standard curve;
FIG. 2 is a urokinase standard curve;
FIG. 3 is a microscope (100X) photograph of strain GZU 05;
FIG. 4 is a phylogenetic tree diagram of strain GZU 05.
Detailed Description
The following examples serve to further illustrate the invention:
EXAMPLE 1 preparation of seed liquid culture Medium, Nattokinase and beta-glucosidase crude enzyme solution
1) Preparing a seed liquid culture medium (g/L), 10 parts of glucose, 5 parts of yeast extract, 10 parts of beef extract and 5 parts of NaCl, selecting 2-3 cyclomycelia from a slant, inoculating the mixture into the liquid seed culture medium, and culturing for 18 hours at 37 ℃ under the condition of 180 r/min.
2) The preparation method of the crude enzyme liquid of nattokinase and beta-glucosidase comprises the following steps: adding 10g of NaCl and 10g of glucose into each liter of deionized water according to the mass part ratio, heating to completely dissolve, cooling, and drying the beans: deionized water 1: 4 soaking the commercial non-transgenic soybeans completely in an immersion manner for 18 hours. Then the mixture is drained and filled into 50/250 triangular bottles for sterilization. Inoculating the seed liquid to the cooled solid fermentation culture medium according to the inoculation amount of 2-4%, culturing at 37 ℃ for 72h, and shaking once every 12h to form a fermented product. Extracting the fermented product with physiological saline at 4 deg.C for 24 hr, grinding with mortar, centrifuging at 4 deg.C under centrifugal force of 12000 × g for 12-18min, collecting supernatant, and breaking cells to obtain crude enzyme solution of beta-glucosidase and nattokinase;
Example 2: and (3) measuring the enzyme activity of the beta-glucosidase:
1) drawing a glucose standard curve: sucking 0, 0.2mL, 0.4mL, 0.6mL, 0.8mL and 1.0mL of anhydrous glucose solution of 1mg/mL into a test tube with a plug scale, supplementing water to 2mL, adding 3mL of DNS reagent, mixing, boiling in boiling water for 10min, cooling, adding water to fix the volume to 15mL, and measuring the absorbance at the wavelength of 540nm of a spectrophotometer; taking the absorbance as the ordinate and the glucose amount as the abscissa, drawing a standard curve, and taking a linear regression equation as y ═
0.5841x +0.0044, R2 ═ 0.9991 (fig. 1);
(2) and (3) measuring the enzyme activity of the beta-glucosidase: detecting the enzyme activity of the beta-glucosidase of the strain by a DNS method, and selecting the strain with higher enzyme activity; taking a 15mL test tube with a plug scale, adding 1.8mL of a substrate (1% of one of ginkgo flavonoid glycoside or amygdalin, geniposide, rutin, gentiobiose, maltotriose, arbutin, laminarin and trehalose), preheating at 50 ℃ for 3min, adding 0.2mL of enzyme solution, carrying out water bath at 50 ℃ for 30min, adding 3mL of DNS reagent, carrying out boiling water bath for 10min, cooling and fixing the volume to 15 mL. The absorbance was measured at 540nm using the inactivated enzyme solution as a blank control. And calculating the enzyme activity of the beta-glucosidase in the sample according to a regression equation of a glucose concentration standard curve.
Definition of beta-glucosidase enzyme activity unit: under the measurement conditions, the amount of enzyme required to hydrolyze ginkgo flavone glycosides to produce 1. mu. mol of reducing sugars (in terms of glucose) per 1min was defined as 1 enzyme activity unit (U).
GZU05 the beta-glucosidase enzyme produced by fermented soya beans hydrolyzes ginkgo flavone glycosides with an enzyme activity of 3.696U/g, which is higher than that of enzyme hydrolyzing other substrates, and shows high selectivity to ginkgo flavone glycosides.
Example 3: nattokinase activity assay
The activity of the natto kinase enzyme is defined as follows: measuring the diameter of the lysis rings by using a vernier caliper, calculating the area of each lysis ring, and calculating the enzyme activity of the sample nattokinase according to a regression equation of a urokinase standard curve.
Preparation of urokinase standard curve: respectively preparing urokinase standard substances into 248IU/m L, 496IU/m L, 744IU/m L, 992IU/m L and 1240IU/m L, spotting 10 mu L of the urokinase standard substances into newly prepared fibrinogen flat plate holes (4 holes are parallel to 1 group), placing for 10min, culturing at 37 ℃ for 16h, taking out, measuring the diameter of a lysis ring, and calculating the area of each lysis ring; in terms of the area (x, mm) of the dissolving ring2) Urokinase standard curve is plotted with urokinase enzyme activity (y, IU/mL) as abscissa and urokinase enzyme activity (y, IU/mL) as ordinate. The linear regression equation is that y is 4.2016x +10.874, and R2 is 0.9994 (fig. 2). Then GZU05 is tested, and the nattokinase activity of the fermented natto is 6861U- g。
Example 4: precisely measuring the nattokinase by an ultraviolet spectrophotometry:
the ultraviolet spectrophotometer method is a measuring method which is established by the Japan nattokinase society and can accurately reflect the fibrinolytic activity of the nattokinase, and is also one of the world-recognized nattokinase activity measuring methods. The method has the advantages that the fibrinolytic activity content of the nattokinase can be objectively obtained, and various samples can be simultaneously detected. Because the measured value of the agarose-fibrinogen plate method is easy to change along with the change of the culture time and the thickness of the plate, the accuracy is poor and the sample measurement with high accuracy requirement is not suitable. The specific method comprises the following steps: 1.4mL of Tris-HCl (50mM, pH 7.8) buffer and 0.4mL of fibrinogen solution (7.2mg/mL) were added to the tube, incubated at 37 ℃ for 5min, then 0.1mL of thrombin (20U/mL) was added, further incubated at 37 ℃ for 10min to form an artificial thrombus, 0.1mL of a sample to be tested was added, incubated at 37 ℃ for 60min, 2mL of trichloroacetic acid (0.2moL/L) solution was added, the reaction was stopped by standing for 20min, centrifuged at 13000 r/min for 10min, and the supernatant was taken out and the absorbance was measured at a wavelength of 275 nm. Definition of enzyme activity: the amount of enzyme required for an increase in absorbance at 275nm of 0.01 per 1min was defined as 1 unit of fibrin-degrading enzyme activity. The nattokinase activity of the nattokinase obtained after GZU05 solid-state fermented natto is precisely measured for 36 hours by an ultraviolet spectrophotometry method reaches 116 FU/g.
Example 5: GZU05 solid state fermentation natto sensory evaluation and scoring condition
(1) GZU05 sensory evaluation of strain solid state fermentation: the fermented and cooked natto is scored by a weighting method, sensory evaluation is respectively carried out on four aspects of wire drawing (viscosity), color, smell and property and behavior, each index is divided into five grades, 10 professional persons respectively evaluate the indexes, and the average value, the scoring standard and the scoring weight are shown in table 1.
TABLE 1 sensory Scoring criteria for fermented products
(2) Sensory evaluation results of solid fermented natto
Good production strains are the basis for ensuring food fermentation, and selection of strains with good organoleptic properties is a prerequisite for subsequent fermentation. Inoculating GZU05 strain into solid fermentation culture medium containing semen glycines as main raw material, culturing under the same fermentation condition, recording the wire drawing length, color, smell and taste of each strain fermentation product, and calculating the comprehensive score of 4.2. The fermented natto is yellow to light yellow, and has long-term wiredrawing phenomenon when fermented soybeans are stirred, has light fragrance, coordinated fragrance and uniform posture, and the nattokinase activity in the fermented soybeans is higher than 6000U/g (wet soybeans).
Example 6: colony morphology identification, physiological and biochemical identification and 16SrRNA molecular biology identification
The strain is cultured on a screening medium plate for 48 hours, and the colony morphology and the colony color are observed and recorded.
Gram staining: selecting bacterial colonies on the flat plate for smear, fixation, crystal violet initial staining, mordant staining, decoloration, water washing, safranin counterstaining, drying and microscopic examination.
Observing the colony morphology characteristics of the strain, wherein the bacterial colony of the strain has an obvious blue bacteria ring, the bulge has wrinkles, and after gram staining, observing the cell morphology characteristics under an oil microscope of an optical microscope, and the result is shown in figure 3.
And (3) carrying out physiological and biochemical characteristic identification on the bacillus amyloliquefaciens GZU05, wherein the physiological and biochemical characteristics of the bacillus amyloliquefaciens GZU05, namely carbon source utilization, are shown in table 2, and the physiological and biochemical characteristics, enzyme activity and carbon source assimilation of the bacillus amyloliquefaciens GZU05 are shown in table 3.
The phylogenetic dendrogram of the bacillus amyloliquefaciens GZU05 is shown in fig. 4.
TABLE 2 Biochemical Properties of Strain GZU05 production of acid Using carbon Source
Note: +: positive, -: the negative result is negative, and the negative result is negative,
TABLE 3 physiological and biochemical characteristics of Strain GZU 05-enzyme Activity, carbon Source assimilation
Note: +: positive reaction; -: negative reaction; w: weak positive reaction
<110> Guizhou university
He Laping
<120> bacillus amyloliquefaciens GZU05 for producing nattokinase and beta-glucoside enzymolysis and application method thereof
<130> 11111111
<160> 1
<170> PatentIn version 3.5
<210> 1
<211> 1449
<212> DNA
<213> Bacillus amyloliquefaciens (Bacillus amyloliquefaciens)
<220>
<221> 16S rRNA
<222> (1)..(1449)
<400> 1
atggcgcgtg ctatacatgc aagtcgagcg gacagatggg agcttgctcc ctgatgttag 60
cggcggacgg gtgagtaaca cgtgggtaac ctgcctgtaa gactgggata actccgggaa 120
accggggcta ataccggatg gttgtctgaa ccgcatggtt cagacataaa aggtggcttc 180
ggctaccact tacagatgga cccgcggcgc attagctagt tggtgaggta acggctcacc 240
aaggcgacga tgcgtagccg acctgagagg gtgatcggcc acactgggac tgagacacgg 300
cccagactcc tacgggaggc agcagtaggg aatcttccgc aatggacgaa agtctgacgg 360
agcaacgccg cgtgagtgat gaaggttttc ggatcgtaaa gctctgttgt tagggaagaa 420
caagtgccgt tcaaataggg cggcaccttg acggtaccta accagaaagc cacggctaac 480
tacgtgccag cagccgcggt aatacgtagg tggcaagcgt tgtccggaat tattgggcgt 540
aaagggctcg caggcggttt cttaagtctg atgtgaaagc ccccggctca accggggagg 600
gtcattggaa actggggaac ttgagtgcag aagaggagag tggaattcca cgtgtagcgg 660
tgaaatgcgt agagatgtgg aggaacacca gtggcgaagg cgactctctg gtctgtaact 720
gacgctgagg agcgaaagcg tggggagcga acaggattag ataccctggt agtccacgcc 780
gtaaacgatg agtgctaagt gttagggggt ttccgcccct tagtgctgca gctaacgcat 840
taagcactcc gcctggggag tacggtcgca agactgaaac tcaaaggaat tgacgggggc 900
ccgcacaagc ggtggagcat gtggtttaat tcgaagcaac gcgaagaacc ttaccaggtc 960
ttgacatcct ctgacaatcc tagagatagg acgtcccctt cgggggcaga gtgacaggtg 1020
gtgcatggtt gtcgtcagct cgtgtcgtga gatgttgggt taagtcccgc aacgagcgca 1080
acccttgatc ttagttgcca gcattcagtt gggcactcta aggtgactgc cggtgacaaa 1140
ccggaggaag gtggggatga cgtcaaatca tcatgcccct tatgacctgg gctacacacg 1200
tgctacaatg gacagaacaa agggcagcga aaccgcgagg ttaagccaat cccacaaatc 1260
tgttctcagt tcggatcgca gtctgcaact cgactgcgtg aagctggaat cgctagtaat 1320
cgcggatcag catgccgcgg tgaatacgtt cccgggcctt gtacacaccg cccgtcacac 1380
cacgagagtt tgtaacaccc gaagtcggtg aggtaacctt tatggagcca gccgccgaaa 1440
ggggacccc 1449
Claims (1)
1. Bacillus amyloliquefaciens (Latin academy name: Bacillus amyloliquefaciens) GZU05 capable of producing nattokinase and beta-glucoside enzymolysis starch is characterized in that the Bacillus amyloliquefaciens is preserved in the China center for type culture collection (CCTCC M2018763) in 2018, 11 and 9 months; the address of the preservation unit is Wuhan, Wuhan university, whose postcode is 430072 and telephone number is 027-one 68754952.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910025309.9A CN109797115B (en) | 2019-01-12 | 2019-01-12 | Bacillus amyloliquefaciens GZU05 for producing nattokinase and beta-glucoside and application method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910025309.9A CN109797115B (en) | 2019-01-12 | 2019-01-12 | Bacillus amyloliquefaciens GZU05 for producing nattokinase and beta-glucoside and application method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109797115A CN109797115A (en) | 2019-05-24 |
CN109797115B true CN109797115B (en) | 2022-07-12 |
Family
ID=66557008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910025309.9A Active CN109797115B (en) | 2019-01-12 | 2019-01-12 | Bacillus amyloliquefaciens GZU05 for producing nattokinase and beta-glucoside and application method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109797115B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110438027B (en) * | 2019-06-05 | 2022-08-26 | 贵州大学 | Bacillus amyloliquefaciens strain GUTU06 producing multiple enzymes and screening method thereof |
CN111154674B (en) * | 2020-01-09 | 2021-07-23 | 齐鲁工业大学 | Bacillus subtilis for fermenting pea natto and application thereof |
CN112048524A (en) * | 2020-08-28 | 2020-12-08 | 哈尔滨工业大学 | Method for improving dark fermentation hydrogen production performance by using ginkgetin |
CN113174335B (en) * | 2021-04-19 | 2022-06-17 | 广西大学 | Separation method of banana colletotrichum gloeosporioides |
CN116790565A (en) * | 2023-08-14 | 2023-09-22 | 广东牧豆人农业科技有限公司 | Method for extracting nattokinase by utilizing bacillus natto fermented bean dregs |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002000856A2 (en) * | 2000-06-30 | 2002-01-03 | Flanders Interuniversity Institute For Biotechnology (Vib) | Protein glycosylation modification in pichia pastoris |
WO2020169564A1 (en) * | 2019-02-20 | 2020-08-27 | Basf Se | Industrial fermentation process for bacillus using defined medium and trace element feed |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9931381B2 (en) * | 2009-11-23 | 2018-04-03 | Prothera, Inc. | Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
CN107828685A (en) * | 2017-11-15 | 2018-03-23 | 江苏大学 | A kind of bacillus subtilis mutagenic strain of high-yield nattokinase and its application |
-
2019
- 2019-01-12 CN CN201910025309.9A patent/CN109797115B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002000856A2 (en) * | 2000-06-30 | 2002-01-03 | Flanders Interuniversity Institute For Biotechnology (Vib) | Protein glycosylation modification in pichia pastoris |
WO2020169564A1 (en) * | 2019-02-20 | 2020-08-27 | Basf Se | Industrial fermentation process for bacillus using defined medium and trace element feed |
Non-Patent Citations (2)
Title |
---|
豆豉发酵中的微生物和功能性组分研究动态;汪孟娟等;《中国微生态学杂志》;20100130;第22卷(第01期);81-84 * |
豆豉活性成分的研究进展;孙成行等;《食品研究与开发》;20060928;第27卷(第09期);157-159 * |
Also Published As
Publication number | Publication date |
---|---|
CN109797115A (en) | 2019-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109797115B (en) | Bacillus amyloliquefaciens GZU05 for producing nattokinase and beta-glucoside and application method thereof | |
Okafor et al. | Studies on the microbiology of cassava retting for foo‐foo production | |
CN113813203B (en) | Cherry blossom enzymolysis fermentation product and preparation method and application thereof | |
CN113832083B (en) | Bacillus beleisi and application thereof in vinegar brewing | |
US20210139938A1 (en) | Aspergillus oryzae blcy-006 strain and application thereof in preparation of galactooligosaccharide | |
CN109852558B (en) | Bacillus subtilis GZU03 for producing beta-glucosidase and nattokinase and application method thereof | |
Okorie et al. | Growth and extracellular enzyme production by microorganisms isolated from Ugba-an indigenous Nigerian fermented condiment | |
CN103937691B (en) | One plant production β fructosidases aspergillus oryzae strain and its cultural method and application | |
CN113750008B (en) | Jasmine flower enzymolysis fermentation product and preparation method and application thereof | |
Ni et al. | Identification and characterization of a new naringinase-producing strain, Williopsis californica Jmudeb007 | |
CN117448182A (en) | Aroma-producing yeast and culture method and application thereof | |
CN110438027B (en) | Bacillus amyloliquefaciens strain GUTU06 producing multiple enzymes and screening method thereof | |
CN107012222A (en) | It is a kind of that preparation method is oriented based on the pickle starter that 16S rDNA are sequenced | |
CN109456898A (en) | A kind of the fermentation preparation and its application of chaetomium globosum dextranase | |
CN107760609B (en) | A kind of suitable macromolecule of production under alkaline condition, the bacterial strain of non-pigment pulullan polysaccharide and its application | |
CN102199559B (en) | Bacillus subtilis strain and application thereof | |
Sani et al. | Isolation, partial purification and characterization of α-amylase from Bacillus subtilis | |
CN111621429B (en) | High-yield ester Mao Zhenbi red yeast and application thereof in fermentation of jujube fruit wine | |
CN107488601A (en) | One plant height produces bacterial strain and its application of the resistance to acidproof β glucuroides of sugar | |
Oyeleke et al. | Production of bacterial amylase by Bacillus species isolated from rice husk dumpsites in Sokoto metropolis, Nigeria | |
JP2785323B2 (en) | β-glucosidase and method for producing the same | |
CN108552406A (en) | A kind of method of multi-cultur es combined fermentation mushroom bran | |
CN116286557B (en) | Salt-tolerant bacillus beijerinckii for producing cellulase and culture method thereof | |
CN114958630B (en) | Pichia pastoris strain capable of producing glucuronic acid and application thereof | |
CN107118972B (en) | Can liquid fermentation produce pectin Solidago Canadensis endogenetic fungus and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231031 Address after: 430000, 1st floor, Building C4, Optics Valley Biotech, No. 666 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee after: CHANGE INNOVATION (WUHAN) BIO-TECH Co.,Ltd. Address before: 550025 Huaxi District, Guizhou, Guiyang Patentee before: Guizhou University |